Canopy Growth logo

WEED - Canopy Growth Share Price

C$34.76 0.4  1.2%

Last Trade - 16/04/21

Large Cap
Market Cap £7.57bn
Enterprise Value £7.24bn
Revenue £292.7m
Position in Universe 61st / 2713
Unlock WEED Revenue
Relative Strength (%)
1m -22.1%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -51.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
2.37 12.7 39.9 77.9 226.3 398.8 557.4 796 +178.7%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, CanopyGrowth Corp revenues increased 37% to C$398.2M. Net lossincreased from C$18.3M to C$1.04B. Revenues reflectRecreational cannabis revenue segment increase from C$68.7Mto C$206M, Other revenue segment increase from C$33.4M toC$128.7M, Canada segment increase from C$80.7M to C$243.1M,Outside of canada segment increase from C$43M to C$155.1M.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


WEED Revenue Unlock WEED Revenue

Net Income

WEED Net Income Unlock WEED Revenue

Normalised EPS

WEED Normalised EPS Unlock WEED Revenue

PE Ratio Range

WEED PE Ratio Range Unlock WEED Revenue

Dividend Yield Range

WEED Dividend Yield Range Unlock WEED Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
WEED EPS Forecasts Unlock WEED Revenue
Profile Summary

Canopy Growth Corp, formerly Tweed Marijuana Inc, is a Canada-based multi-brand cannabis company. The Company, through its subsidiaries Tweed Inc, Bedrocan Canada Inc, Tweed Farms Inc and Mettrum Health Corp is engaged in the business of producing and selling legal marijuana in the Canadian medical market. It is also focusing on producing and selling marijuana in the recreational market in Canada. Its core brands are Tweed and Bedrocan. Tweed is a licensed producer of medical marijuana. Tweed's commercial license covers approximately 168,000 square feet of its Smiths Falls facility and allows Tweed to produce and sell approximately 3,540 kilograms of medical marijuana per year. Tweed's built-out production capacity is over 10 climate controlled indoor growing rooms. Bedrocan is a medical-grade cannabis. Bedrocan's over 52,000 square feet production facility in Toronto, Ontario is licensed, and includes over 30 vegetative and growing rooms, and over three dispensing rooms.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated August 5, 2009
Public Since June 4, 2010
No. of Shareholders: n/a
No. of Employees: 4,434
Sector Healthcare
Industry Pharmaceuticals
Index S&P/TSX Composite , S&P - Tse 300 Capped ,
Exchange Toronto Stock Exchange
Shares in Issue 376,840,247
Free Float (0.0%)
Eligible for
WEED Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for WEED
Upcoming Events for WEED
Tuesday 1st June, 2021
Q4 2021 Canopy Growth Corp Earnings Release - Tentative
Monday 9th August, 2021 Estimate
Q1 2022 Canopy Growth Corp Earnings Release
Tuesday 21st September, 2021 Estimate
Canopy Growth Corp Annual Shareholders Meeting
Frequently Asked Questions for Canopy Growth
What is the Canopy Growth share price?

As of 16/04/21, shares in Canopy Growth are trading at C$34.76, giving the company a market capitalisation of £7.57bn. This share price information is delayed by 15 minutes.

How has the Canopy Growth share price performed this year?

Shares in Canopy Growth are currently trading at C$34.76 and the price has moved by 70.39% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Canopy Growth price has moved by 26.63% over the past year.

What are the analyst and broker recommendations for Canopy Growth?

Of the analysts with advisory recommendations for Canopy Growth, there are there are currently 1 "buy" , 10 "hold" and 4 "sell" recommendations. The overall consensus recommendation for Canopy Growth is Sell. You can view the full broker recommendation list by unlocking its StockReport.

When will Canopy Growth next release its financial results?

Canopy Growth is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Canopy Growth dividend yield?

Canopy Growth does not currently pay a dividend.

Does Canopy Growth pay a dividend?

Canopy Growth does not currently pay a dividend.

When does Canopy Growth next pay dividends?

Canopy Growth does not currently pay a dividend.

How do I buy Canopy Growth shares?

To buy shares in Canopy Growth you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Canopy Growth?

Shares in Canopy Growth are currently trading at C$34.76, giving the company a market capitalisation of £7.57bn.

Where are Canopy Growth shares listed? Where are Canopy Growth shares listed?

Here are the trading details for Canopy Growth:

Country of listing: Canada
Exchange: TOR
Ticker Symbol: WEED
What kind of share is Canopy Growth?

Based on an overall assessment of its quality, value and momentum, Canopy Growth is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Canopy Growth share price forecast 2021?

Shares in Canopy Growth are currently priced at C$34.76. At that level they are trading at 18.15% discount to the analyst consensus target price of 0.00.

Analysts covering Canopy Growth currently have a consensus Earnings Per Share (EPS) forecast of -3.013 for the next financial year.

How can I tell whether the Canopy Growth share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Canopy Growth. Over the past six months, the relative strength of its shares against the market has been 24.74%. At the current price of C$34.76, shares in Canopy Growth are trading at 7.35% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Canopy Growth PE Ratio?

We were not able to find PE ratio data for Canopy Growth.

Who are the key directors of Canopy Growth?

Canopy Growth's management team is headed by:

Rade Kovacevic - PRE
Mike Lee - CFO
David Klein - CEO
Robert Hanson - IND
William Newlands - IND
Judy Schmeling - CHM
Phillip Shaer - OTH
Theresa Yanofsky - IND
David Lazzarato - IND
Thomas Shipley - SVP
Thomas Stewart - CAO
Jimes Sabia - DRC
Who are the major shareholders of Canopy Growth?

Here are the top five shareholders of Canopy Growth based on the size of their shareholding:

CBG Holdings, L.L.C. Corporation
Percentage owned: 27.73% (104.5m shares)
Greenstar Canada Investment, L.P. Corporation
Percentage owned: 10.02% (37.8m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 1.74% (6.57m shares)
ETFMG Alternative Harvest ETF Mutual Fund
Percentage owned: 0.84% (3.17m shares)
ETF Managers Group, LLC Investment Advisor
Percentage owned: 0.78% (2.96m shares)
Similar to WEED
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.